China’s Ad5-nCoV COVID-19 Vaccine Granted Conditional Marketing Authorization
This week, the China National Medical Products Administration (NMPA) granted conditional marketing authorization of Recombinant COVID-19 Vaccine (Adenovirus Type 5 […]
Pakistan Procures 10.6m Doses of Ad5-nCoV for $14 Per Dose but Seeks to Diversify with Other Vaccine Makers
CanSino Biologics, one of China’s leading vaccine makers, inked a deal with Pakistan’s government to sell the Ad5-nCoV vaccine candidate […]
CanSino Biologics Inks Deal with Malaysian Holding Company to Prepare Commercialization & Distribution of Ad5-nCoV COVID-19 Vaccine
Indonesia is preparing to support the commercialization of CanSino Biologics’ Ad5-nCoV vaccine candidate as Solution Biologics Sdn Bhd (SOLBIO), a […]
CanSino Biologics’ Ad5-nCOV Tested in Phase 3 Clinical Trials in Russia
According to local reports out of Russia (Moscow Times), the Phase 3 clinical trial investigating Cansino Biologics’ COVID-19 vaccine candidate, […]
People’s Liberation Army Helped China Develop Ad5-nCoV COVID-19 Vaccine, While State-Owned SinoPharm’s Vaccine Moves Toward Approval
At present, there are eight COVID-19 vaccines nearing the end of final trials, and four of these are from China. […]
Russian Petrovax Embraces Ad5-nCoV & Brings into Russia for Phase 3 Clinical Trials
www.petrocax.com, a Russian pharmaceutical company has inked a deal with CanSino Biologics (CanSinoBIO) to drive Phase 3 clinical trials in Russia. The […]
Pakistan Selects Ad5-nCoV for Phase 3 COVID-19 Vaccine Trial Led by CRO Dimension Research CRO & SMO
The Drug Regulatory Authority of Pakistan (DRAP) awarded approval to the National institute of Health (NIH) to embrace CanSino Biologics’ […]
Beijing Grants Ad5-nCOV Patent: the First Such COVID-19 Vaccine in China
CanSino Biologics was granted the first patent approval from the Chinese government in Beijing for its COVID-19 vaccine called Ad5-nCOV, […]
Canada Implements Plan B: Embraces Project LightSpeed Securing Access to BNT162 & Mitigating Risk Associated with Ad5-nCoV
Canada made the timely move to strike a deal with the Project Lightspeed sponsors Pfizer and BioNTech SE to diversity […]
COVID-19 Vaccine Race Moves to Halifax as Canadian Volunteers Eager to Participate in CanSino Biologics Study of Ad5-nCoV
Just hours after an announcement by Justin Trudeau, Prime Minister of Canada, that the nation’s first COVID-19 vaccine clinical trial […]
